Saturday, May 21, 2022 8:50:01 AM
Recent CMPX News
- Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 10/04/2024 02:31:45 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/09/2024 04:15:10 AM
- Compass Therapeutics to Participate in Upcoming Investor Events • GlobeNewswire Inc. • 09/03/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/30/2024 09:23:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 12:49:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 12:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:00:18 PM
- Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:07:16 PM
- Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference • GlobeNewswire Inc. • 08/07/2024 12:00:00 PM
- Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:32:02 PM
- Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Compass Therapeutics Announces CEO Transition • GlobeNewswire Inc. • 05/28/2024 08:10:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:09:10 PM
- Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meet • GlobeNewswire Inc. • 05/23/2024 09:05:00 PM
- Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 12:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 12:00:36 PM
- Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in Combination with Paclitaxel for the Treatment of Patients with Metastatic or Locally Advanced Biliary Tract Tumors That Have Been Previously Treated • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference • GlobeNewswire Inc. • 04/12/2024 12:00:00 PM
- Compass Therapeutics to Participate in the Stifel Targeted Oncology Days • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting • GlobeNewswire Inc. • 04/09/2024 04:00:00 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM